YAE-26483-40711
5 vaccinations
6 coded responses
39 check-ins
6 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 100 / NY
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-07
Registered in v-safe
- 2021-03-07
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-03-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-20
-
2021-03-27
Dose 2 — Pfizer-BioNTech
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-10
- 2021-04-17
-
2021-04-24
Survey response — day 28, dose 2MedDRA: Hypoaesthesia — Feeling: FairFree text: Numbness in toes - unclear whether or not this has any relationship to the vaccine or notMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Survey response — day 35, dose 2MedDRA: Hypoaesthesia — Feeling: FairFree text: Continued numbness in toes, as I mentioned last weekMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-08
Survey response — day 42, dose 2MedDRA: Hypoaesthesia — Feeling: GoodFree text: Continued numbness in toes, as I have indicated for each of the past several weeksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-26
Survey response — 3 months, dose 2MedDRA: Hypoaesthesia, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: I continue to experience numbness in certain toes (which numbness commenced shortly after COVID vaccination) and am concerned about the possibility of Distal Sensory Neuropathy, though I do not yet have a diagnosis. · Healthcare visit (other): Doctor's office visit & labsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-26
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-01
- 2021-09-27
-
2021-11-24
Dose 3 — Pfizer-BioNTech
-
2021-11-25
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-11-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-11-27
- 2021-11-30
- 2021-12-02
- 2021-12-09
- 2021-12-15
-
2021-12-22
Survey response — day 28, dose 3MedDRA: Rhinorrhoea — Feeling: FairFree text: SnifflesMedDRA releases: 2024-11 · check-in free text available
- 2021-12-29
- 2022-01-06
- 2022-02-25
-
2022-04-21
Dose 4 — Moderna
- 2022-05-19
- 2022-05-29
- 2022-06-02
-
2022-07-23
Survey response — 3 months, dose 4MedDRA: Hypoaesthesia — Feeling: FairFree text: Loss of sensation in middle toesMedDRA releases: 2024-11 · check-in free text available
- 2022-10-20
-
2022-11-04
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2023-04-21
- 2023-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech | |
| 2 | 2021-03-27 | Pfizer-BioNTech | |
| 3 | 2021-11-24 | Pfizer-BioNTech | No |
| 4 | 2022-04-21 | Moderna | No |
| 5 | 2022-11-04 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-26 | Unsuccessful |
Free text
Release 7 — day 28, dose 2
Symptoms: Numbness in toes - unclear whether or not this has any relationship to the vaccine or not
Release 8 — day 35, dose 2
Symptoms: Continued numbness in toes, as I mentioned last week
Release 8 — day 42, dose 2
Symptoms: Continued numbness in toes, as I have indicated for each of the past several weeks
Release 9 — 3 months, dose 2
Symptoms: I continue to experience numbness in certain toes (which numbness commenced shortly after COVID vaccination) and am concerned about the possibility of Distal Sensory Neuropathy, though I do not yet have a diagnosis.
Healthcare visit (other): Doctor's office visit & labs
Release 10 — day 28, dose 3
Symptoms: Sniffles
Release 12 — 3 months, dose 4
Symptoms: Loss of sensation in middle toes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release